Related Experiment Video
Updated: Dec 25, 2025

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
Extracellular signal-regulated kinases (ERK) 1 and 2 as a key molecule in pain research
Masahiro Kondo1, Ikuko Shibuta2
1Department of Legal Medicine, Nihon University School of Dentistry.
Abstract:
Pain can be divided into nociceptive, inflammatory, and neuropathic pain. It is important to understanding the molecular mechanism of pain signaling in the development of pain relief therapies. Twenty years ago, extracellular signal-regulated kinases (ERK) 1 and 2, which are members of the mitogen-activated protein kinase superfamily, were identified as molecules activated in neurons by the exposure of peripheral tissues to noxious stimuli. Further studies have revealed that peripheral nerve injury induces ERK activation in glial cells, sensory neurons, and second-order neurons, albeit at different time points. Moreover, inhibition of ERK suppresses pathological pain in animals with peripheral nerve injury. Therefore, ERK is currently recognized as an important molecule in pain signaling and a potential novel target for pain treatment. This review introduces recent advances in revealing the regulation of ERK in pain research.
Insights
Extracellular signal-regulated kinases (ERK) 1 and 2 are crucial in pain signaling pathways. Inhibiting ERK shows promise for treating pathological pain, highlighting its potential as a novel therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Pain Research
Background:
- Pain is classified into nociceptive, inflammatory, and neuropathic types.
- Understanding pain's molecular mechanisms is key for developing effective pain relief therapies.
- Extracellular signal-regulated kinases (ERK) 1 and 2, part of the mitogen-activated protein kinase superfamily, were identified 20 years ago.
Purpose of the Study:
- To review recent advances in understanding the regulation of ERK in pain research.
- To highlight the role of ERK in pain signaling pathways.
- To explore the potential of ERK as a novel therapeutic target for pain management.
Main Methods:
- Review of existing literature on ERK activation in pain signaling.
- Analysis of studies investigating the effects of ERK inhibition on pathological pain.
- Examination of ERK expression patterns in various neuronal and glial cells following peripheral nerve injury.
Main Results:
- Peripheral nerve injury induces ERK activation in glial cells, sensory neurons, and second-order neurons at distinct time points.
- Inhibition of ERK signaling effectively suppresses pathological pain in animal models of peripheral nerve injury.
- ERK is confirmed as a significant molecule involved in pain signaling.
Conclusions:
- ERK plays a critical role in the molecular mechanisms of pain signaling.
- ERK represents a promising novel target for the development of new pain relief therapies.
- Further research into ERK regulation is essential for advancing pain treatment strategies.
Related Concept Videos
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Pain
Nociception

